Hojun Li, a clinical investigator at the Koch Institute, speaks with Juli McDonald on CBS Boston about his efforts to develop a test that can determine a person’s Covid immunity. “We wanted to develop a way in which we could very quickly and easily assess whether [immunocompromised people] were still protected from that vaccine or that previous infection they had,” said Li.
Daily Beast reporter Tony Ho Tran writes that a new paper test developed by MIT researchers could be used to help determine a person’s immune response to Covid-19. “The researchers believe that the new test can not only help folks find out if they should get boosted,” writes Tran, “but also help the most vulnerable populations make sure they’re protected against the coronavirus, and help people make more informed decisions on what kinds of activities they should feel safe doing.”
Boston.com reporter Madeleine Aitken writes that MIT researchers have created a new blood test that can measure immune protection against Covid-19. The new test measures the “level of neutralizing antibodies in a blood sample, using the same type of ‘lateral flow’ technology as antigen tests,” writes Aitken.
Researchers from MIT and Harvard have developed a “3D-printed ‘lab-on-a-chip’ that could detect Covid-19 immunity levels and Covid infections from saliva within two hours,” reports Ben Leonard and Ruth Reader for Politico.
Boston Herald reporter Rick Sobey writes that MIT researchers have developed a blood test that can predict Covid-19 immunity. “The MIT researchers created a paper test that measures the level of neutralizing antibodies in a blood sample, which could help people decide what protections they should take against infection,” writes Sobey. “Their test uses the same type of 'lateral flow' technology as most rapid antigen tests for Covid.”
Researchers from MIT and other institutions have developed a postcard-sized test that can detect a Covid-19 infection and the presence of antibodies resulting from an infection, reports Maddie Bender for the Daily Beast. “What excites me about this diagnostic device is that it combines a high level of accuracy with a flexible design that could make it a major tool in our arsenal for addressing future pandemics,” explains Prof. James Collins.
Newsha Ghaeli ’17 - president and co-founder of Biobot, a public health research, data and analytics firms that has developed and promoted wastewater surveillance technology - speaks with Vox reporter Muizz Akhtar about how wastewater surveillance can be used to predict and prepare for future pandemics. “Our vision is that this is a permanent infrastructure layer on our sewer systems, so that it becomes one of the core kinds of pandemic preparedness in this country and disease surveillance globally,” says Ghaeli.
Using machine learning techniques, MIT researchers analyzed social media sentiment around the world during the early days of the Covid-19 pandemic and found that the “pandemic precipitated a dramatic drop in happiness,” reports Charlotte Hu for Popular Science. “We wanted to do this global study to compare different countries because they were hit by the pandemic at different times,” explains Prof. Siqi Zheng, “and they have different cultures, different political systems, and different healthcare systems.”
Writing for The Boston Globe, Prof. Edward Scolnick and La Jolla Institute for Immunology Prof. Erica Ollmann Saphire share their insights on the future and potential challenges in developing a universal Covid-19 vaccine. “Success will require two principles that the world has not yet sufficiently grasped in fighting this virus: a focus on the long term over the short term, and a sustainable structure and support for collaboration,” write Scolnick and Saphire.
Prof. Mariana Arcaya writes for The Boston Globe about how the Bipartisan Infrastructure Investment and Jobs Act, and the Build Beck Better bill will help combat the ongoing global climate crisis. “Shifting away from fossil-fuel consumption and combatting injustice are the two keys to solving the climate crisis,” writes Arcaya. “The Bipartisan Infrastructure Act provides vital funding for some of the measures the United States needs to take.”
Boston Globe Magazine reporter Courtney Humphries spotlights MIT startup Biobot Analytics, co-founded by Mariana Matus ’18 and Newsha Ghaeli ’17, for using their wastewater and sewage tracking technology to identify Covid -19 in communities across the United States. “Because people shed the virus in their stool before they test positive, Biobot’s data are often a leading indicator of where the infection is heading, arriving ahead of case counts by a few days,” writes Humphries.
MIT researchers have found a way to use wastewater testing surveillance as a public health tool to identify infectious diseases, reports Marie Szaniszlo for the Boston Herald. “Wastewater testing first started with a discovery by MIT researchers is being used nationwide as an early warning sign,” writes Szaniszlo.
Bloomberg reporter Chris Anstey spotlights a new study by MIT researchers that finds that during the Covid-19 pandemic people have been taking cues from their neighbors as to whether it is safe to resume social activities like dining in restaurants. “We felt that in [some] uncertain times, such information might be particularly valuable,” said Prof. Siqi Zheng. “If others think it’s safe to go out, then maybe I should feel safe. To be sure, we were also prepared for the opposite reaction, that people would hunker down and try to avoid crowds.”
In an article for The Washington Post, Visiting Professor Susan Blumenthal and Emily Stark of New America make the case for creating a “government-backed program that would evaluate and label masks for consumers like the Food and Drug Administration does for sunscreens.”
Boston Globe reporter Pranshu Verma spotlights MIT startup Biobot Analytics, co-founded by Mariana Matus ’18 and Newsha Ghaeli ’17, for their work studying sewage data to better predict the spread of Covid-19 in communities. “For health officials, it [the data] confirms whether Covid spikes in the community are real, and not due to increased testing or other factors,” writes Verma. “Moreover, Covid levels in waste water are a leading indicator for new clinical cases, giving health officials a few days’ notice if they’ll see more sick patients showing symptoms.”